{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:27:02Z","timestamp":1787272022471,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The authors are grateful for financial support from the Immunology Research Center, Tabriz University of Medical Science."},{"name":"Immunology Research Center, Tabriz University of Medical Science","award":["78233"],"award-info":[{"award-number":["78233"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42840-1","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:45:24Z","timestamp":1779803124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced antimicrobial and anticancer properties of penicillin G\u2013adapted Lacticaseibacillus rhamnosus GG against colorectal cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Fardin","family":"Soltani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Zahra","family":"Bahojb Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Eskandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Memar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Pourbagherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Ali","family":"Mokhtarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"42840_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy. Signal. Transduct. Target. Therapy. 9 (1), 266 (2024).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"42840_CR2","doi-asserted-by":"publisher","first-page":"113325","DOI":"10.1016\/j.intimp.2024.113325","volume":"143","author":"S Saha","year":"2024","unstructured":"Saha, S., Ghosh, S., Ghosh, S., Nandi, S. & Nayak, A. Unraveling the complexities of colorectal cancer and its promising therapies\u2013An updated review. Int. Immunopharmacol. 143, 113325 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"42840_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3389\/fimmu.2020.01624","volume":"11","author":"NA Johdi","year":"2020","unstructured":"Johdi, N. A. & Sukor, N. F. Colorectal cancer immunotherapy: Options and strategies. Front. Immunol. 11, 1624 (2020).","journal-title":"Front. Immunol."},{"issue":"14","key":"42840_CR4","doi-asserted-by":"publisher","first-page":"7937","DOI":"10.3390\/ijms25147937","volume":"25","author":"L-F Herlo","year":"2024","unstructured":"Herlo, L-F. et al. Gut microbiota signatures in colorectal cancer as a potential diagnostic biomarker in the future: A systematic review. Int. J. Mol. Sci. 25 (14), 7937 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"42840_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/cells13171437","volume":"13","author":"NK Shakhpazyan","year":"2024","unstructured":"Shakhpazyan, N. K. et al. Exploring the role of the gut microbiota in modulating colorectal cancer immunity. Cells 13 (17), 1437 (2024).","journal-title":"Cells"},{"issue":"6510","key":"42840_CR6","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager, L. F. et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369 (6510), 1481\u20131489 (2020).","journal-title":"Science"},{"issue":"19","key":"42840_CR7","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.3390\/molecules26196076","volume":"26","author":"X Wang","year":"2021","unstructured":"Wang, X., Zhang, P. & Zhang, X. Probiotics regulate gut microbiota: An effective method to improve immunity. Molecules 26 (19), 6076 (2021).","journal-title":"Molecules"},{"key":"42840_CR8","doi-asserted-by":"publisher","first-page":"1143548","DOI":"10.3389\/fimmu.2023.1143548","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Probiotics fortify intestinal barrier function: A systematic review and meta-analysis of randomized trials. Front. Immunol. 14, 1143548 (2023).","journal-title":"Front. Immunol."},{"key":"42840_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/MCG.0000000000001170","volume":"53","author":"L Capurso","year":"2019","unstructured":"Capurso, L. Thirty years of Lactobacillus rhamnosus GG: A review. J. Clin. Gastroenterol. 53, S1\u2013S41 (2019).","journal-title":"J. Clin. Gastroenterol."},{"issue":"1_Supplement","key":"42840_CR10","doi-asserted-by":"publisher","first-page":"12004","DOI":"10.4049\/jimmunol.208.Supp.120.04","volume":"208","author":"L Wang","year":"2022","unstructured":"Wang, L., Liang, H. L. & Weichselbaum, R. Lactobacillus rhamnosus GG re-shapes gut microbiota and triggers STING-type I IFN-dependent antitumor immunity. J. Immunol. 208 (1_Supplement), 12004\u201312004 (2022).","journal-title":"J. Immunol."},{"key":"42840_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-019-0299-4","volume":"11","author":"Z Fei","year":"2019","unstructured":"Fei, Z. et al. Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer. Gut Pathogens. 11, 1\u201310 (2019).","journal-title":"Gut pathogens"},{"issue":"10","key":"42840_CR12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/ijc.31836","volume":"144","author":"KR Secombe","year":"2019","unstructured":"Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R. & Bowen, J. M. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity. Int. J. Cancer. 144 (10), 2365\u20132376 (2019).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"42840_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000443360","volume":"34","author":"K Lange","year":"2016","unstructured":"Lange, K., Buerger, M., Stallmach, A. & Bruns, T. Effects of antibiotics on gut microbiota. Dig. Dis. 34 (3), 260\u2013268 (2016).","journal-title":"Dig. Dis."},{"issue":"1","key":"42840_CR14","first-page":"135","volume":"90","author":"M Lobanovska","year":"2017","unstructured":"Lobanovska, M. & Pilla, G. Penicillin\u2019s Discovery and Antibiotic Resistance: Lessons for the Future? Yale J. Biol. Med. 90 (1), 135\u2013145 (2017).","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"42840_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/toxsci\/kfw150","volume":"154","author":"Y Jin","year":"2016","unstructured":"Jin, Y. et al. From the cover: exposure to oral antibiotics induces gut microbiota dysbiosis associated with lipid metabolism dysfunction and low-grade inflammation in mice. Toxicol. Sci. 154 (1), 140\u2013152 (2016).","journal-title":"Toxicol. Sci."},{"issue":"1","key":"42840_CR16","doi-asserted-by":"publisher","first-page":"15062","DOI":"10.1038\/ncomms15062","volume":"8","author":"S Leclercq","year":"2017","unstructured":"Leclercq, S. et al. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat. Commun. 8 (1), 15062 (2017).","journal-title":"Nat. Commun."},{"key":"42840_CR17","unstructured":"Ghorbani, H., Memar, M. Y., Sefidan, F. Y., Yekani, M. & Ghotaslou, R. In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa. GMS Hygiene Infect. Control ;12. (2017)."},{"issue":"10","key":"42840_CR18","doi-asserted-by":"publisher","first-page":"7891","DOI":"10.1007\/s00210-024-03130-7","volume":"397","author":"SS Azadi","year":"2024","unstructured":"Azadi, S. S. et al. Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy. Naunyn. Schmiedebergs Arch. Pharmacol. 397 (10), 7891\u20137903 (2024).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"42840_CR19","doi-asserted-by":"publisher","first-page":"29726","DOI":"10.1038\/s41598-025-12805-x","volume":"15","author":"M Hejazi","year":"2025","unstructured":"Hejazi, M. et al. LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis. Sci. Rep. 15 (1), 29726 (2025).","journal-title":"Sci. Rep."},{"issue":"3","key":"42840_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.34172\/apb.2023.053","volume":"13","author":"S Najafi","year":"2022","unstructured":"Najafi, S. et al. CD44 suppression improved the chemosensitivity of HT-29 colorectal cancer cells to 5-fluorouracil and inhibited cell migration. Adv. Pharm. Bull. 13 (3), 551 (2022).","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"42840_CR21","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1038\/s41598-025-87649-6","volume":"15","author":"SG Alamdari","year":"2025","unstructured":"Alamdari, S. G. et al. Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression. Sci. Rep. 15 (1), 7971 (2025).","journal-title":"Sci. Rep."},{"issue":"9","key":"42840_CR22","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1007\/s00210-024-03060-4","volume":"397","author":"SZ Bahojb Mahdavi","year":"2024","unstructured":"Bahojb Mahdavi, S. Z. et al. Let-7a-3p overexpression increases chemosensitivity to carmustine and synergistically promotes autophagy and suppresses cell survival in U87MG glioblastoma cancer cells. Naunyn Schmiedebergs Arch. Pharmacol. 397 (9), 6903\u20136918 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"7","key":"42840_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong, C. C. & Yu, J. Gut microbiota in colorectal cancer development and therapy. Nat. Reviews Clin. Oncol. 20 (7), 429\u2013452 (2023).","journal-title":"Nat. Reviews Clin. Oncol."},{"issue":"56","key":"42840_CR24","doi-asserted-by":"publisher","first-page":"30919","DOI":"10.18632\/oncotarget.25778","volume":"9","author":"TE Ichim","year":"2018","unstructured":"Ichim, T. E., Kesari, S. & Shafer, K. Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement. Oncotarget 9 (56), 30919\u201330935 (2018).","journal-title":"Oncotarget"},{"issue":"1","key":"42840_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-024-04991-5","volume":"22","author":"R Hu","year":"2024","unstructured":"Hu, R. et al. Autoinducer-2 promotes the colonization of Lactobacillus rhamnosus GG to improve the intestinal barrier function in a neonatal mouse model of antibiotic-induced intestinal dysbiosis. J. Translational Med. 22 (1), 177 (2024).","journal-title":"J. Translational Med."},{"issue":"3","key":"42840_CR26","first-page":"1139","volume":"43","author":"L Chen","year":"2019","unstructured":"Chen, L., Li, H., Li, J., Chen, Y. & Yang, Y. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis. Int. J. Mol. Med. 43 (3), 1139\u20131148 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"42840_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fphar.2017.00603","volume":"8","author":"GL Banna","year":"2017","unstructured":"Banna, G. L. et al. Lactobacillus rhamnosus GG: an overview to explore the rationale of its use in cancer. Front. Pharmacol. 8, 603 (2017).","journal-title":"Front. Pharmacol."},{"key":"42840_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3389\/fmicb.2019.00841","volume":"10","author":"F Gaucher","year":"2019","unstructured":"Gaucher, F. et al. Adaptation of beneficial Propionibacteria, lactobacilli, and Bifidobacteria improves tolerance toward technological and digestive stresses. Front. Microbiol. 10, 841 (2019).","journal-title":"Front. Microbiol."},{"key":"42840_CR29","doi-asserted-by":"crossref","unstructured":"Rozman, V. et al. Genomic insights into antibiotic resistance and mobilome of lactic acid bacteria and bifidobacteria. Life Sci. alliance ;6(4). (2023).","DOI":"10.26508\/lsa.202201637"},{"key":"42840_CR30","doi-asserted-by":"publisher","first-page":"e00853","DOI":"10.1128\/msystems.00853-19","volume":"5","author":"C Cao","year":"2020","unstructured":"Cao, C. et al. Adaptation of Lactobacillus plantarum to ampicillin involves mechanisms that maintain protein homeostasis. mSystems 5, e00853\u2013e00819 (2020).","journal-title":"mSystems"},{"key":"42840_CR31","doi-asserted-by":"publisher","first-page":"147823","DOI":"10.1016\/j.gene.2023.147823","volume":"891","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhang, R., Wang, B., Song, S. & Zhang, F. Evaluation of penicillin-resistance and probiotic traits in Lactobacillus plantarum during laboratory evolution. Gene 891, 147823 (2024).","journal-title":"Gene"},{"issue":"1","key":"42840_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.30.1.1","volume":"30","author":"F Malouin","year":"1986","unstructured":"Malouin, F. & Bryan, L. E. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrob. Agents Chemother. 30 (1), 1\u20135 (1986).","journal-title":"Antimicrob. Agents Chemother."},{"key":"42840_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13099-018-0235-z","volume":"10","author":"P Jarocki","year":"2018","unstructured":"Jarocki, P. et al. Complete genome sequence of Lactobacillus rhamnosus Pen, a probiotic component of a medicine used in prevention of antibiotic-associated diarrhoea in children. Gut Pathog. 10, 5 (2018).","journal-title":"Gut Pathog"},{"issue":"1","key":"42840_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1574-6968.2006.00250.x","volume":"259","author":"SC De Keersmaecker","year":"2006","unstructured":"De Keersmaecker, S. C. et al. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol. Lett. 259 (1), 89\u201396 (2006).","journal-title":"FEMS Microbiol. Lett."},{"issue":"2","key":"42840_CR35","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jam.12544","volume":"117","author":"M Coman","year":"2014","unstructured":"Coman, M. et al. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501\u00ae, Lactobacillus paracasei IMC 502\u00ae and SYNBIO\u00ae against pathogens. J. Appl. Microbiol. 117 (2), 518\u2013527 (2014).","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"42840_CR36","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s00210-024-03636-0","volume":"398","author":"F Gholipour","year":"2025","unstructured":"Gholipour, F. et al. In vitro effects of crocin on the possible anticancer properties of Lactococcus lactis against colorectal adenocarcinoma cells. Naunyn Schmiedebergs Arch. Pharmacol. 398 (5), 5729\u20135741 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"42840_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.fbio.2018.05.005","volume":"24","author":"R Salmanzadeh","year":"2018","unstructured":"Salmanzadeh, R. et al. Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics. Food bioscience. 24, 37\u201345 (2018).","journal-title":"Food bioscience"},{"key":"42840_CR38","doi-asserted-by":"publisher","first-page":"985363","DOI":"10.3389\/fonc.2022.985363","volume":"12","author":"S Qian","year":"2022","unstructured":"Qian, S. et al. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol. 12, 985363 (2022).","journal-title":"Front. Oncol."},{"issue":"3","key":"42840_CR39","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/febs.14186","volume":"285","author":"A Pe\u00f1a-Blanco","year":"2018","unstructured":"Pe\u00f1a-Blanco, A., Garc\u00eda\u2010S\u00e1ez, A. J. & Bax Bak and beyond\u2014mitochondrial performance in apoptosis. FEBS J. 285 (3), 416\u2013431 (2018).","journal-title":"FEBS J."},{"key":"42840_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall, M., Rodriguez-Menocal, L., De Guevara, R. L., Cepero, E. & Boise, L. H. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 14, 1\u20139 (2013).","journal-title":"BMC Cell Biol."},{"issue":"6","key":"42840_CR41","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1007\/s11033-023-08445-x","volume":"50","author":"M Amin","year":"2023","unstructured":"Amin, M., Navidifar, T., Saeb, S., Barzegari, E. & Jamalan, M. Tumor-targeted induction of intrinsic apoptosis in colon cancer cells by Lactobacillus plantarum and Lactobacillus rhamnosus strains. Mol. Biol. Rep. 50 (6), 5345\u20135354 (2023).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"42840_CR42","first-page":"68","volume":"16","author":"N Erfanian","year":"2024","unstructured":"Erfanian, N. et al. Investigating the therapeutic potential of Bifidobacterium breve and Lactobacillus rhamnosus postbiotics through apoptosis induction in colorectal HT-29 cancer cells. Iran. J. Microbiol. 16 (1), 68 (2024).","journal-title":"Iran. J. Microbiol."},{"key":"42840_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-016-0433-9","volume":"35","author":"R Visconti","year":"2016","unstructured":"Visconti, R., Della Monica, R. & Grieco, D. Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword. J. Experimental Clin. Cancer Res. 35, 1\u20138 (2016).","journal-title":"J. Experimental Clin. Cancer Res."},{"issue":"4","key":"42840_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.34172\/bi.2021.32","volume":"11","author":"N Dehghani","year":"2021","unstructured":"Dehghani, N., Tafvizi, F. & Jafari, P. Cell cycle arrest and anti-cancer potential of probiotic Lactobacillus rhamnosus against HT-29 cancer cells. Bioimpacts 11 (4), 245\u2013252 (2021).","journal-title":"Bioimpacts"},{"issue":"1","key":"42840_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41416-020-01149-0","volume":"124","author":"NM Novikov","year":"2021","unstructured":"Novikov, N. M., Zolotaryova, S. Y., Gautreau, A. M. & Denisov, E. V. Mutational drivers of cancer cell migration and invasion. Br. J. Cancer. 124 (1), 102\u2013114 (2021).","journal-title":"Br. J. Cancer"},{"key":"42840_CR46","doi-asserted-by":"publisher","first-page":"663978","DOI":"10.3389\/fphys.2021.663978","volume":"12","author":"J Wan","year":"2021","unstructured":"Wan, J. et al. Matrix metalloproteinase 3: A promoting and destabilizing factor in the pathogenesis of disease and cell differentiation. Front. Physiol. 12, 663978 (2021).","journal-title":"Front. Physiol."},{"issue":"7","key":"42840_CR47","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/cancers14071847","volume":"14","author":"K Augoff","year":"2022","unstructured":"Augoff, K., Hryniewicz-Jankowska, A., Tabola, R. & Stach, K. MMP9: A tough target for targeted therapy for cancer. Cancers 14 (7), 1847 (2022).","journal-title":"Cancers"},{"key":"42840_CR48","unstructured":"Lee, J. Anti-cancer effect of Lactobacillus rhamnosus GG extract on human malignant melanoma cell lines (\uc11c\uc6b8\ub300\ud559\uad50 \ub300\ud559\uc6d0, 2018)."},{"issue":"4","key":"42840_CR49","first-page":"559","volume":"19","author":"F Maghsood","year":"2018","unstructured":"Maghsood, F. et al. Dual effects of cell free supernatants from Lactobacillus acidophilus and Lactobacillus rhamnosus GG in regulation of MMP-9 by up-regulating TIMP-1 and down-regulating CD147 in PMA-differentiated THP-1 cells. Cell. J. (Yakhteh). 19 (4), 559 (2018).","journal-title":"Cell. J. (Yakhteh)"},{"issue":"5","key":"42840_CR50","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1 (5), 2315\u20132319 (2006).","journal-title":"Nat. Protoc."},{"issue":"10","key":"42840_CR51","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1136\/gutjnl-2020-323951","volume":"71","author":"N Sugimura","year":"2022","unstructured":"Sugimura, N. et al. Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis. Gut 71 (10), 2011\u20132021 (2022).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42840-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42840-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42840-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:03:38Z","timestamp":1787270618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42840-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42840-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26241"}}